论文信息 - High dose cisplatin and high dose carboplatin in refractory ovarian cancer. - 字舞流文

High dose cisplatin and high dose carboplatin in refractory ovarian cancer.

Y. Ostchega | R. Ozols | R. Young | B. Behrens

[1] Y. Ostchega,et al. High-dose cisplatin in hypertonic saline in refractory ovarian cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2] R C Young,et al. Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches. , 1984, Seminars in oncology.

[3] Y. Ostchega,et al. High-dose cisplatin in hypertonic saline. , 1984, Annals of internal medicine.

[4] S. Harland,et al. Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma. , 1983, Cancer treatment reports.

[5] R. Ozols,et al. A Phase I and Pharmacokinetic Study of Diamminecyclobutanedicarboxylatoplatinum (NSC 241240) , 1983 .

[6] A. Calvert,et al. JM8, SUCCESSOR TO CISPLATIN IN ADVANCED OVARIAN CARCINOMA? , 1983, The Lancet.

[7] E. Wiltshaw,et al. USE OF HIGH DOSE CIS‐DICHLORODIAMMINE PLATINUM (II) (NSC—119875) † FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED CARCINOMA OF THE OVARY , 1981, British journal of obstetrics and gynaecology.

[8] C. Cohen,et al. High-dose platinum for the treatment of refractory ovarian cancer. , 1981, Gynecologic oncology.